An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Dana Drzayich Antol
Adrianne Waldman Casebeer
Richard W. DeClue
Stephen Stemkowski
Patricia A. Russo
机构：
[1] Comprehensive Health Insights,
[2] Novartis Pharmaceuticals Corporation,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Cardiology; Dyspnea; Ejection fraction; Fatigue; Heart failure; Hospitalization; Sacubitril/valsartan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：785 / 795
页数：10
相关论文
共 50 条
  • [41] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [42] Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Godet, M.
    Raitiere, O.
    Chopra, H.
    Guignant, P.
    Fauvel, C.
    Gaudin, K.
    Eltchaninoff, H.
    Beuer, F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 735 - 735
  • [43] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [44] PARAGON-HF - considerations for potential use of sacubitril-valsartan in real-world heart failure with mildly reduced ejection fraction
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (12) : 1012 - 1013
  • [45] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [46] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [47] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [48] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [49] DIASTOLIC FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED BY SACUBITRIL/VALSARTAN
    Lamaida, N.
    Cerciello, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [50] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Barman, Hasan Ali
    Tanyolac, Selim
    Dogan, Omer
    Bal, Erdem
    Atici, Adem
    Ozyildirim, Serhan
    Yigit, Zerrin
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 533 - 540
12345